Physician-researcher David Ouyang, MD, to bring longstanding expertise to Journal focused on artificial intelligence and machine learning
News | Artificial Intelligence
Smidt Heart Institute Expert Named Deputy Editor of NEJM AI

January 17, 2024 — One of the Smidt Heart Institute’s leading experts in artificial intelligence, David Ouyang, MD, has ...

Home January 17, 2024
Home
The application of AI technology in the diagnosis of cardiovascular diseases using coronary CT angiography (CCTA) has gradually deepened
News | Artificial Intelligence
Artificial Intelligence Helps Coronary CT Angiography and Accelerates the Development of Precision Medicine

January 17, 2024 — This review was jointly published by Prof. Long-Jiang Zhang (Department of Radiology, Jinling ...

Home January 17, 2024
Home
Satya Shreenivas, MD, MBA has joined the company as Chief Medical Officer.
News | Heart Failure
Cardiac Dimensions Appoints Satya Shreenivas, MD, as Chief Medical Officer

January 16, 2024 — Cardiac Dimensions, a leader in the development of innovative and minimally invasive treatment ...

Home January 16, 2024
Home
Pilot program to deploy highly portable technology to be rolled out later this year 
News | Artificial Intelligence
Novel AI Platform Matches Cardiologists in Detecting Rheumatic Heart Disease

January 16, 2024 — Artificial intelligence (AI) has the potential to detect rheumatic heart disease (RHD) with the same ...

Home January 16, 2024
Home
Latest technology combines superior catheter design and sustained aspiration to maximize blood clot removal from the coronary vasculature
News | Thrombectomy Devices
Penumbra Launches Indigo System CAT RX Catheter in Europe to Address Acute Coronary Syndrome

January 16, 2024 — Penumbra, Inc., a thrombectomy company, has recently secured CE Mark (Conformité Européenne) for its ...

Home January 16, 2024
Home
A public-private partnership Think Tank
News | Cardiovascular Education
Cardiac Safety Research Consortium Announces Think Tank Program with FDA Regulators, Industry and Academia Focused on Cardiac Remote Monitoring Trials and AI

January 15, 2024 — A public-private partnership Think Tank, scheduled for Feb. 29-March 1, will be presented by the ...

Home January 15, 2024
Home
Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the University of Oxford, UK, has entered into an agreement with Pfizer to support the validation and FDA clearance of its AI-based technology for the detection of cardiac amyloidosis.
News | Artificial Intelligence
Ultromics Announces Partnership to Expedite Development of Echo AI Algorithm for Early Detection of Cardiac Amyloidosis

January 15, 2024 — Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the ...

Home January 15, 2024
Home
Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology.
News | Stroke
Goldstein Selected to Help Lead Statewide Task Force Addressing Heart Disease and Stroke

January 15, 2024 — Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology, has been selected ...

Home January 15, 2024
Home
Webinar addresses driving efficiency while maintaining diagnostic performance.
News | Computed Tomography (CT)
SPONSORED CONTENT: Webinar on Applying SMART-CT Results to Daily Clinical Practice

HeartFlow is offering a free webinar based on a recent study that measured the ability of the of its roadmap analysis to ...

Home January 15, 2024
Home
ATTRibute-CM demonstrated a significant treatment effect of acoramidis on the primary endpoint (a hierarchical analysis inclusive of all-cause mortality (ACM) and frequency of cardiovascular-related hospitalization (CVH)), with a Win Ratio of 1.8 (p<0.0001)
News | Pharmaceuticals
BridgeBio Pharma Announces Publication of Positive Results from Phase 3 ATTRibute-CM Study of Acoramidis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in the New England Journal of Medicine

January 12, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

Home January 12, 2024
Home
An unprecedented collaboration between an eminent heart surgeon, a Michelin-starred chef and a global cardiovascular device provider sees the launch of a unique, surgically inspired recipe book, conceived to help surgeons practice their surgical dexterity in an unexpected way
News | Cardiovascular Business
A World-first Collaboration to Help Heart Surgeons Utilize Their Dexterity in an Unexpected Way – Introducing The Heart Surgeon’s Cookbook

January 12, 2024 — The Heart Surgeon’s Cookbook is the brainchild of New York-based Cardiovascular and Thoracic Surgeon ...

Home January 12, 2024
Home
New CVi Image
News | Contrast Media Injectors
WEBINAR NOW AVAILABLE ON DEMAND: Contrast Management in Modern PCI

On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI." ...

Home January 11, 2024
Home
It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of the passing of Bruce Wilkoff, MD, FHRS
News | EP Lab
In Memoriam: Bruce Wilkoff, MD, FHRS

January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of ...

Home January 11, 2024
Home
The Journal of Lung and Heart Transplantation (JHLT) has published a real-world study indicating a significant reduction in Primary Graft Dysfunction (PGD), a severe post-transplant complication ― potentially allowing for an increase in donor hearts available for heart transplant patients
News | Cardiovascular Surgery
Paragonix SherpaPak Recognized for Maximizing Access to the Donor Pool in New Clinical Study

January 11, 2024 — Paragonix Technologies, a pioneer in organ transplant solutions, is proud to announce the publication ...

Home January 11, 2024
Home
The cumulative incidence of MACE and all- cause of mortality in COVID-19 and non-COVID-19 pneumonia groups.
News | Coronavirus (COVID-19)
Chung-Ang University Study Looks at Cardiovascular Risks in COVID-19 Survivors

January 11, 2024 — Acute cardiovascular manifestations of COVID-19, such as heart failure, thrombosis, and dysrhythmia ...

Home January 11, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now